
January • February • March • April • May • June | |
VOLUME 6, NUMBER 1 (January 2009) | |
![]() |
Zoledronic acid improves disease-free survival in hormone-responsive early breast cancer Renal cell cancer: clinical presentation and prognosis Are your patients satisified with your practice? Practical biostatistics: drug trial phases Hereditary diffuse gastric cancer: lifesaving potential of prophylactic gastrectomy Optimizing the dasatinib dose regimen in chronic phase CML Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
VOLUME 6, NUMBER 2 (February 2009) | |
![]() |
Advances in multiple myeloma treatment: lenalidomide and bortezomib Data-driven medical decision-making in managing CINV Cancer genetic counseling in rural North Carolina oncology clinics Practical biostatistics: random clinical trials Building a patient-focused office culture Ischemic myositis in a diabetic patient receiving chemotherapy Sildenafil- and tadalafilassociated optic neuropathy Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
VOLUME 6, NUMBER 3 (March 2009) | |
![]() |
Identifying and treating imatinib failure in chronic myelogenous leukemia Personalized therapy for cancer: has pharmacogenetics delivered? 5-Fluorouracil–induced cardiotoxicity: hints for predicting patients at risk Elevated alpha-fetoprotein levels and liver lesions in the absence of hepatocellular carcinoma Cremophor EL-containing paclitaxel-induced anaphylaxis The tallest order: fixing the economy and healthcare Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
VOLUME 6, NUMBER 4 (April 2009) | |
![]() |
Community Oncology interviews Barbara A. Goff, MD Incorporating genomic classifiers in clinical pathways for early breast cancer Preoperative evaluation, diagnosis, and staging of rectal cancer Traditional and emerging therapies for renal cell cancer Practical biostatistics: data variables and distributions A clustering of breast, lung, and fallopian tube cancers Sharpening your communication skills Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
VOLUME 6, NUMBER 5 (May 2009) | |
![]() |
Degarelix, a new GnRH antagonist, in prostate cancer Clinical trial awareness, attitudes, and participation among patients with cancer and oncologists Ixabepilone: a new treatment option for resistant metastatic breast cancer Practical biostatistics: understanding meta-analysis Brain metastasis from non-small cell lung cancer: sustained response with erlotinib Three pillars of healthcare reform Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
VOLUME 6, NUMBER 6 (June 2009) | |
![]() |
Update on HPV vaccination and HPV screening Impact of NCD guidelines on Medicare patients with chemotherapy-induced anemia Management of rectal cancer: part II Management of chronic lymphocytic leukemia: an update Treating chemotherapy-induced anemia following the revised labeling for ESAs Practical biostatistics: P less than 0.05: statistical inference Small cell carcinoma of the lung with paraneoplastic features Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
VOLUME 6, NUMBER 7 (July 2009) | |
![]() |
Advances in neoadjuvant therapies for early breast cancer Novel therapies in metastatic head and neck squamous cell cancer Primary signet-ring cell carcinoma of the ileum Implementing clinical trials: The centralized network model Rivaroxaban for thromboprophylaxis in major orthopedic surgery Increasing patient satisfaction: office design and quality care Embedding palliative care and geriatric oncology within a private oncology practice Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
VOLUME 6, NUMBER 8 (August 2009) | |
![]() |
PARP inhibitors in breast cancer Surgical management of colorectal liver metastases Dispensing oral medications: why now and how? Using serum levels of HER2/neu to manage metastatic breast cance BRCA1/2 testing in patients with newly diagnosed breast cancer Applying breast cancer risk prediction models in clinical practice Practical biostatistics: noninferiority trials Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
VOLUME 6, NUMBER 9 (September 2009) | |
![]() |
Bevacizumab in recurrent glioblastoma Outcomes in chemotherapy-treated cancer patients receiving ESAs Detecting office fraud in your practice Muir-Torre syndrome associated with a mutation in MSH6 Oxaliplatin-induced eosinophilic pneumonia Prostate cancer in men 40 years of age and younger Practical biostatistics: diagnostic testing Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
VOLUME 6, NUMBER 10 (October 2009) | |
![]() |
Role of MRI in the screening and management of breast cancer Radiation therapy: effective, costly, evolving and paying for it Regional radiotherapy and melanoma Stereotactic body radiotherapy for primary and oligometastatic cancers Helical tomotherapy in the community setting Radiotherapy in patients with a pacemaker or implantable cardioverter-defibrillator Practical biostatistics: efficacy and effectiveness trials Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
VOLUME 6, NUMBER 11 (November 2009) | |
![]() |
Influenza 2009: what you and your patients need to know Time and costs associated with preparing and administering zoledronic acid Genetic counseling and testing for Li-Fraumeni syndrome Early detection and prevention of fraud Extracavitary primary effusion lymphoma in an HIV-positive patient Practical biostatistics: biases in randomized controlled trials Technology: iPhone meets iDoc Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |
VOLUME 6, NUMBER 12 (December 2009) | |
![]() |
Trastuzumab in HER2-positive advanced esophagogastric adenocarcinoma Compliance with adjuvant radiotherapy after surgery for primary breast cancer Guideline adherence with adjuvant hormonal therapy for breast cancer in women 45 and older The role of community oncologists in the prevention and treatment of VTE ITP in elderly patients: practicing with S. Gerald Sandler, MD Practical biostatistics: measures of disease frequency and mortality The health-care debate betrays our heritage Complete Table of Contents FREE FULL TEXT IN PDF FORMAT |